Comments for ImmunoCellular (IMUC.OB): Taking Aim at the Root of Cancer at http://www.biomedreports.com , comment 1 to 3 out of 3 comments http://www.biomedreports.com Wed, 08 Feb 2012 17:04:54 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/200908266925/immunocellular-imucob-taking-aim-at-the-root-of-cancer.html#comment-720 I checked out NWBO as well and while they are the hidden play at the moment, they are not sitting on a nice cash pos. like IMUC is.. Their burn rate is high and we haven't seen another update in their funding.. Does anyone have any info. regarding this? Having said this, it'll be interesting to see if indeed NWBO gets acquired at some pt. in the near future. Manish Singh who is the CEO of IMUC (being that he's a former bio venture capitalist) also hinted at being acquired within two years.. It def. seems like his goal to accomplish this type of exit strategy. - RMax Thu, 27 Aug 2009 17:20:57 +0100 http://www.biomedreports.com/200908266925/immunocellular-imucob-taking-aim-at-the-root-of-cancer.html#comment-707 Thanks for the heads-up on NWBO. IMUC attracted my attention because of the presentation last week in which the CEO guided for a possible partnership and data on the monoclonal antibody front before year-end and the guidance for an IND filing during 1Q10 for the ICT-121. - Mike Havrilla Wed, 26 Aug 2009 11:09:09 +0100 http://www.biomedreports.com/200908266925/immunocellular-imucob-taking-aim-at-the-root-of-cancer.html#comment-706 ... Looks like IMUC uses the same technology (dendric cell) as Northwest Biotherapeutic (NWBO) who is a little further along with their clinical trial to treat the astrocytoma or GBM, the most sever type of brain cancer. Take a look at NWBO. - B. Mao Wed, 26 Aug 2009 08:12:48 +0100